{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:40:05Z","timestamp":1791855605327,"version":"4.3.4"},"reference-count":39,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1254\/jphs.09152fp","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T10:41:22Z","timestamp":1253270482000},"page":"82-90","source":"Crossref","is-referenced-by-count":22,"title":["Contribution of Chymase-Dependent Angiotensin II Formation to the Progression of Tubulointerstitial Fibrosis in Obstructed Kidneys in Hamsters"],"prefix":"10.1254","volume":"111","author":[{"given":"Yu-Yan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyasu","family":"Kiyomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050232"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005070757"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 el-Dahr SS, Gee J, Dipp S, Hanss BG, Vari RC, Chao J. Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am J Physiol. 1993;264:F874–F881.","DOI":"10.1152\/ajprenal.1993.264.5.F874"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Yoo KH, Norwood VF, el-Dahr SS, Yosipiv I, Chevalier RL. Regulation of angiotensin II AT1 and AT2 receptors in neonatal ureteral obstruction. Am J Physiol. 1997;273:R503–R509.","DOI":"10.1152\/ajpregu.1997.273.2.R503"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.183"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi045"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 El Chaar M, Chen J, Seshan SV, Jha S, Richardson I, Ledbetter SR, et al. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2007;292:F1291–F1301.","DOI":"10.1152\/ajprenal.00327.2005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Guo G, Morrissey J, Mccracken R, Tolley T, Klahr S. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol. 1999;277:F766–F772.","DOI":"10.1152\/ajprenal.1999.277.5.F766"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, Chevalier RL. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest. 1999;103:39–46.","DOI":"10.1172\/JCI4236"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, et al. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol. 2001;12:317–325.","DOI":"10.1681\/ASN.V122317"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116325"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.CPJ06008X"},{"key":"13","unstructured":"13 Murakami M, Matsuda H, Kubota E, Wakino S, Honda M, Hayashi K, et al. Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney. Kidney Int Suppl. 1997;63:S132–S135."},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000022060.13995.ED"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590041374.x"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1161\/hy0102.100536"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2007.01.012"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080649"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080676"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005121375"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol. 2002;283:F861–F875.","DOI":"10.1152\/ajprenal.00362.2001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 de Borst MH, van Timmeren MM, Vaidya VS, de Boer RA, van Dalen MB, Kramer AB, et al. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol. 2007;292:F313–F320.","DOI":"10.1152\/ajprenal.00180.2006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol. 2007;292:F330–F339.","DOI":"10.1152\/ajprenal.00059.2006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Turan T, van Harten JG, de Water R, Tuncay OL, Kok DJ. Is enalapril adequate for the prevention of renal tissue damage caused by unilateral ureteral obstruction and\/or hyperoxaluria? Urol Res. 2003;31:212–217.","DOI":"10.1007\/s00240-003-0320-7"},{"issue":"36","key":"25","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","volume":"265","year":"1990","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Petrie MC, Padmanabhan N, Mcdonald JE, Hillier C, Connell JM, Mcmurray JJ. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol. 2001;37:1056–1061.","DOI":"10.1016\/S0735-1097(01)01111-1"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.24.189"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension. 2004;43:1126–1132.","DOI":"10.1161\/01.HYP.0000122875.91100.28"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00476.x"},{"issue":"1 Pt 1","key":"30","first-page":"42","volume":"30","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-005-0509-z"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000140445.82949.54"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Shin GT, Kim WH, Yim H, Kim MS, Kim H. Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-beta1 expression in acute ureteral obstruction. Kidney Int. 2005;67:897–908.","DOI":"10.1111\/j.1523-1755.2005.00154.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kobori H, Ozawa Y, Satou R, Katsurada A, Miyata K, Ohashi N, et al. Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol. 2007;293:F938–F945.","DOI":"10.1152\/ajprenal.00146.2007"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421398"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, et al. The role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol. In Press 2009.","DOI":"10.1111\/j.1440-1681.2009.05172.x"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FMJ05003X2"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.08R10FM"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Nakano D, Pollock DM. Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats. Hypertension. 2009;53:324–330.","DOI":"10.1161\/HYPERTENSIONAHA.108.123687"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T23:50:46Z","timestamp":1633909846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/111\/1\/111_09152FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.09152fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}